Search results
Baidu Stock Analysis: It's Surprisingly Cheap to Bet on China's ChatGPT
InvestorPlace· 7 days agoBaidu (NASDAQ:BIDU) is more than just a search-engine provider. Indeed, with Baidu stock, you’ll get...
Unlocking Crypto Opportunities: How ChatGPT Enhanced My Investment Strategy
Motley Fool via Yahoo Finance· 6 days agoFor example, I've used ChatGPT to delve into the technological aspects of rollups, a complicated...
Chegg's Stock Price Drops 27% As ChatGPT And Free AI Tools Send Stock Plummeting
Benzinga via AOL· 5 days agoChegg Inc. (NYSE:CHGG) faces a substantial challenge from the emergence of AI tools such as ChatGPT,...
Is SoundHound AI Stock a Buy in May?
The Motley Fool via AOL· 19 hours agoThe Nvidia connection SoundHound is a voice AI and speech recognition software company founded in 2005. Despite its initial public offering (IPO) -- a...
Better Tech Stock: Intel vs. AMD
Motley Fool via Yahoo Finance· 21 hours agoAdvances in artificial intelligence (AI) brought the launch of OpenAI's ChatGPT, forcing countless companies to restructure their businesses to...
1 Spectacular Growth Stock Down 67% to Buy Hand Over Fist, According to Wall Street
Motley Fool via Yahoo Finance· 20 hours agoThe number of businesses spending at least $1 million annually jumped 24% to 168. It highlights how...
ChatGPT, Claude, Gemini Or Another? The AI Tool Entrepreneurs Prefer
Forbes· 6 days agoChatGPT had first mover advantage, but the other LLMs are pulling out all the stops with new...
Billionaire Stan Druckenmiller Cut His Massive Nvidia Position. Here's Why.
The Motley Fool via AOL· 21 hours agoNearly $550 million of that amount was held in stock and options of just one company, Nvidia...
How the Medical Industry Could Produce the Biggest AI Stock Winners
InvestorPlace via Yahoo Finance· 7 days agoIt has since been updated to include the most relevant information available. A bulk of the...
Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?
Motley Fool via Yahoo Finance· 18 hours agoAnd, at a time when its coronavirus vaccine revenue is no longer enough to make the stock as...